AU2014363695B2 - Antiparasitic use of isoxazoline compounds - Google Patents

Antiparasitic use of isoxazoline compounds Download PDF

Info

Publication number
AU2014363695B2
AU2014363695B2 AU2014363695A AU2014363695A AU2014363695B2 AU 2014363695 B2 AU2014363695 B2 AU 2014363695B2 AU 2014363695 A AU2014363695 A AU 2014363695A AU 2014363695 A AU2014363695 A AU 2014363695A AU 2014363695 B2 AU2014363695 B2 AU 2014363695B2
Authority
AU
Australia
Prior art keywords
fleas
isoxazoline compound
animal
use according
stages
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
AU2014363695A
Other languages
English (en)
Other versions
AU2014363695A1 (en
Inventor
Anja Regina Heckeroth
Heike Williams
Hartmut Zoller
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Intervet International BV
Original Assignee
Intervet International BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49759099&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AU2014363695(B2) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Intervet International BV filed Critical Intervet International BV
Publication of AU2014363695A1 publication Critical patent/AU2014363695A1/en
Application granted granted Critical
Publication of AU2014363695B2 publication Critical patent/AU2014363695B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/42—Oxazoles
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N43/00—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds
    • A01N43/72—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms
    • A01N43/80—Biocides, pest repellants or attractants, or plant growth regulators containing heterocyclic compounds having rings with nitrogen atoms and oxygen or sulfur atoms as ring hetero atoms five-membered rings with one nitrogen atom and either one oxygen atom or one sulfur atom in positions 1,2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Environmental Sciences (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Agronomy & Crop Science (AREA)
  • Pest Control & Pesticides (AREA)
  • Plant Pathology (AREA)
  • Engineering & Computer Science (AREA)
  • Dentistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
AU2014363695A 2013-12-10 2014-12-09 Antiparasitic use of isoxazoline compounds Active AU2014363695B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP13196539.4 2013-12-10
EP13196539 2013-12-10
PCT/EP2014/076959 WO2015086551A1 (en) 2013-12-10 2014-12-09 Antiparasitic use of isoxazoline compounds

Publications (2)

Publication Number Publication Date
AU2014363695A1 AU2014363695A1 (en) 2016-06-09
AU2014363695B2 true AU2014363695B2 (en) 2018-12-13

Family

ID=49759099

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2014363695A Active AU2014363695B2 (en) 2013-12-10 2014-12-09 Antiparasitic use of isoxazoline compounds

Country Status (14)

Country Link
US (1) US9655884B2 (enExample)
EP (1) EP3079474B1 (enExample)
JP (1) JP6530753B2 (enExample)
CN (1) CN105992517B (enExample)
AU (1) AU2014363695B2 (enExample)
BR (1) BR112016013020B1 (enExample)
CA (1) CA2932790C (enExample)
DK (1) DK3079474T3 (enExample)
ES (1) ES2742815T3 (enExample)
HU (1) HUE046067T2 (enExample)
PL (1) PL3079474T3 (enExample)
PT (1) PT3079474T (enExample)
RU (1) RU2673723C1 (enExample)
WO (1) WO2015086551A1 (enExample)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112017027855B1 (pt) * 2015-06-23 2022-11-16 Intervet International B.V. Composição farmacêutica, seu uso, água potável medicamentosa e método para sua preparação
CN107535510A (zh) * 2017-09-29 2018-01-05 北京科发伟业农药技术中心 一种含fluralaner的组合物
US11648238B2 (en) 2017-12-12 2023-05-16 Intervet Inc. Implantable isoxazoline pharmaceutical compositions and uses thereof
BR112022000982A2 (pt) 2019-07-22 2022-03-08 Intervet Int Bv Forma de dosagem veterinária mastigável macia
AU2020409532A1 (en) * 2019-12-16 2022-05-12 Intervet International B.V. Composition for lice control
JP7724845B2 (ja) 2020-07-24 2025-08-18 エランコ・ユーエス・インコーポレイテッド イソオキサゾリン化合物及びその中間体を作製するための方法
AU2022299287A1 (en) * 2021-06-25 2023-12-14 In The Bowl Animal Health, Inc. Oral feline feed and methods for controlling tick infestations in a feline
DK182016B1 (en) 2023-03-13 2025-05-28 Zoetis Services Llc Degradation of isoxazolines in ozonated sea water

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009024541A2 (en) * 2007-08-17 2009-02-26 Intervet International B.V. Isoxazoline compositions and their use as antiparasitics
WO2013150055A1 (en) * 2012-04-04 2013-10-10 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0119256A4 (en) 1982-09-17 1986-05-14 Edward J Ireland IMPROVED DENTAL BAND IN MATRIX FORM.
CA2262840C (en) * 1996-08-02 2006-12-05 Novartis Ag Improved method for systemic administration of 2,4-dienoic acid-type insecticides to terrestrial mammals
PT1119256E (pt) * 1998-10-09 2003-10-31 Novartis Ag Combinacao oral de lufenurao e nitenpiram contra as pulgas
EP1671941A4 (en) 2003-09-30 2007-12-12 Nissan Chemical Ind Ltd SUBSTITUTED BENZANILIDE COMPOUND AND PEST CONTROL AGENT
CN1930136B (zh) 2004-03-05 2012-02-08 日产化学工业株式会社 异*唑啉取代苯甲酰胺化合物及有害生物防除剂
TWI412322B (zh) 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
EP2151437A4 (en) 2007-03-07 2012-05-02 Nissan Chemical Ind Ltd ISOXAZOLINE SUBSTITUTED BENZAMIDE COMPOUND AND PEST CONTROL AGENT
DE102007028871A1 (de) 2007-06-22 2008-12-24 Clariant International Limited Verfahren zur Herstellung von reinem C.I. Pigment Orange 74
TWI430995B (zh) 2007-06-26 2014-03-21 Du Pont 萘異唑啉無脊椎有害動物控制劑
DK2957284T3 (en) 2007-06-27 2018-02-05 Du Pont PROCEDURE TO CHECK ANIMALS FOR ANIMALS
TWI411395B (zh) 2007-12-24 2013-10-11 Syngenta Participations Ag 殺蟲化合物
CA2747060A1 (en) 2008-12-18 2010-07-15 Novartis Ag Isoxazolines derivatives and their use as pesticide
NZ593135A (en) 2008-12-19 2013-04-26 Novartis Ag Isoxazoline derivatives and their use as pesticide
SG11201404595TA (en) 2012-02-06 2014-09-26 Merial Ltd Parasiticidal oral veterinary compositions comprising systemically-acting active agents, methods and uses thereof

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009024541A2 (en) * 2007-08-17 2009-02-26 Intervet International B.V. Isoxazoline compositions and their use as antiparasitics
WO2013150055A1 (en) * 2012-04-04 2013-10-10 Intervet International B.V. Solid oral pharmaceutical compositions for isoxazoline compounds

Also Published As

Publication number Publication date
CN105992517B (zh) 2020-03-06
EP3079474B1 (en) 2019-07-03
CA2932790A1 (en) 2015-06-18
EP3079474A1 (en) 2016-10-19
PL3079474T3 (pl) 2019-10-31
ES2742815T3 (es) 2020-02-17
WO2015086551A1 (en) 2015-06-18
PT3079474T (pt) 2019-09-10
DK3079474T3 (da) 2019-09-16
CA2932790C (en) 2021-10-12
JP6530753B2 (ja) 2019-06-12
JP2016539960A (ja) 2016-12-22
HUE046067T2 (hu) 2020-02-28
BR112016013020A2 (pt) 2017-08-08
BR112016013020B1 (pt) 2020-12-01
RU2673723C1 (ru) 2018-11-29
US9655884B2 (en) 2017-05-23
US20160303086A1 (en) 2016-10-20
AU2014363695A1 (en) 2016-06-09
CN105992517A (zh) 2016-10-05

Similar Documents

Publication Publication Date Title
AU2014363695B2 (en) Antiparasitic use of isoxazoline compounds
RU2602308C2 (ru) Изоксазолиновые композиции и их применение в качестве противопаразитарных средств
US12128032B2 (en) Use of isoxazoline derivatives for the treatment or prevention of arthropod infestations in poultry
RU2688919C1 (ru) Изоксазолиновые композиции и их применение в провилактике или лечении паразитарных инвазий животных
AU2020404003B2 (en) Parasite control in ruminants
US11903962B1 (en) Isoxazoline complexes and compositions thereof
US20240366572A1 (en) Isoxazoline complexes and compositions thereof
RU2796536C2 (ru) Применение изоксазолиновых соединений на домашней птице
RU2796536C9 (ru) Применение изоксазолиновых соединений на домашней птице
RU2791637C2 (ru) Изоксазолиновые композиции и их применение в профилактике или лечении паразитарных инвазий животных

Legal Events

Date Code Title Description
ON Decision of a delegate or deputy of the commissioner of patents (result of patent office hearing)

Free format text: (2019) APO 33: DECISION: EXTENSION OF TIME ALLOWED UNDER SECTION 223(2)(A) UNTIL 20 MARCH 2019 TO FILE A NOTICE OF OPPOSITION. I AWARD COSTS ACCORDING TO SCHEDULE 8 AGAINST INTERVET INTERNATIONAL B.V.

Opponent name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

Effective date: 20190719

CH Opposition withdrawn

Opponent name: BOEHRINGER INGELHEIM ANIMAL HEALTH USA INC.

FGA Letters patent sealed or granted (standard patent)
NB Applications allowed - extensions of time section 223(2)

Free format text: COMPLETE TASK: OPPOSITION AND CREATE WORKFLOW: MANUAL 20 MAR 2019